Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|July 18, 2023
Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco, Aurora Scrivo, Paul Zumbo, et al.
The Annals of Thoracic Surgery|October 2, 2017
Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural MesotheliomaBryan M Burt, Hyun-Sung Lee, Veronica Lenge De Rosen, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 12, 2013
Clinical indications and results after chest wall resection for recurrent mesotheliomaBryan M Burt, Syed O Ali, Marcelo C DaSilva, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 15, 2014
Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortalityBryan M Burt, Robert B Cameron, Nathan M Mollberg, et al.
Frontiers in Immunology|August 22, 2017
Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal ModelsWilliam K Decker, Rodrigo F da Silva, Mayra H Sanabria, et al.
Annals of Surgical Oncology|August 1, 2015
Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung AdenocarcinomaBryan M Burt, Ann N Leung, Masahiro Yanagawa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2004
Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207)Joseph J Bennett, Prasad Adusumilli, Henrik Petrowsky, et al.
The Annals of Thoracic Surgery|April 7, 2019
Utilization of Minimally Invasive Thymectomy and Margin-Negative Resection for Early-Stage ThymomaBryan M Burt, Duy Nguyen, Shawn S Groth, et al.
The Annals of Thoracic Surgery|January 23, 2021
Staging Concordance and Guideline-Concordant Treatment for Esophageal AdenocarcinomaWilson Luiz da Costa, Xiangjun Gu, Farhood Farjah, et al.
Cancer Gene Therapy|October 19, 2002
Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancerJoseph J Bennett, Keith A Delman, Bryan M Burt, et al.
Pageof 12